Paraneoplastic pemphigus with bronchiolitis obliterans in a child

Pediatric Dermatology

Volumn 20, Issue 3, 2003, Pages 238-242

  Mar, Winnie A ^a,c   Glaesser, Robin ^a   Struble, Kristin ^b   Stephens Groff, Sue ^a   Bangert, Jerry ^a   Hansen, Ronald C ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c Graduate Medical Education Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; ERYTHROMYCIN; FLUDARABINE; GOLD; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; SALBUTAMOL; TACROLIMUS;

ARTICLE; AUTOIMMUNE DISEASE; BRONCHIOLITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MYOFIBROBLASTIC TUMOR; OPEN LUNG BIOPSY; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS; SCHOOL CHILD; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TUMOR DIAGNOSIS;

BIOPSY, NEEDLE; BRONCHIOLITIS OBLITERANS; CHILD; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; GOLD COMPOUNDS; HUMANS; IMMUNOHISTOCHEMISTRY; METHOTREXATE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PREDNISONE; SEVERITY OF ILLNESS INDEX;

EID: 0037972286     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.20311.x     Document Type: Article

References (21)

1. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-1735.
2. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19:859-872.
3. Rybojad M, Leblanc T, Flageul B, et al. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol 1993;128:418-422.
4. Lemon MA, Weston WL, Huff JC. Childhood paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1997;136:115-117.
5. Kim SC, Chang SN, Lee IJ, et al. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1998;138:667-671.
6. Schoen H, Foedinger D, Derfler K, et al. Immunoapheresis in paraneoplastic pemphigus. Arch Dermatol 1998;134:706-710.
7. Gooptu C, Mendelsohn S, Amagai M, Hashimoto T, Nishikawa T, Wojnarowska F. Unique immunobullous disease in a child with a predominantly IgA response to three desmosomal proteins. Br J Dermatol 1999;141:882-886.
8. Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001;137:193-206.
9. Bowen GM, Peters NT, Fivenson DP, et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol 2000;136:652-656.
10. Takahashi M, Shimatsu Y, Kazama T, Kimura K, Otsuka T, Hashimoto T. Paraneoplastic pemphigus associated with bronchiolitis obliterans. Chest 2000;117:603-607.
11. Wolff H, Kunte C, Messer G, et al. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol 1999;140:313-316.
12. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997;12:77-96.
13. Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999;340:1406-1410.
14. Garcia-Rio F, Alvarez-Sala R, Pino JM. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999;341:848.
15. Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ. Successful treatment of paraneoplastic pemphigus in follicular NHL with Rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001;66:142-144.
16. Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hugli A. Anti-CD20 monoclonal antibody (Rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269-272.
17. Williams JV, Marks JG Jr, Billingsley EM. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 2000;142:506-508.
18. Gooptu C, Littlewood TJ, Frith P, et al. Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001;144:1255-1261.
19. Kirsner RS, Anhalt GJ, Kerdel FA. Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995;132:474-478.
20. Fried R, Lynfield Y, Vitale P, Anhalt GJ. Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy. J Am Acad Dermatol 1993;29:815-817.
21. Lee M-S, Kossard S, Ho KKL, et al. Paraneoplastic pemphigus triggered by radiotherapy. Aust J Dermatol 1995;36:206-210.